Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28965774 | 1.00 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10THRB | |
| SCHEMBL9229997 | 1.00 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10THRB | |
| SCHEMBL1160884 | 0.97 | ALDH1A1 (0.42) | ALDH1A1TSHRHSD17B10THRB | |
| Hydrochloric Acid SCHEMBL6464397 | 0.95 | ALDH1A1 (0.41) | ALDH1A1TSHRHSD17B10THRB | |
| SCHEMBL1699179 | 0.87 | HTT (0.36) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL4422860 | 0.87 | HTT (0.41) | ALDH1A1TSHRHSD17B10 | |
| SCHEMBL4419652 | 0.85 | HTT (0.44) | ALDH1A1TSHR | |
| SCHEMBL454517 | 0.83 | — | — | |
| SCHEMBL19304546 | 0.83 | — | — | |
| SCHEMBL8845606 | 0.80 | TSHR (0.46) | ALDH1A1TSHRHSD17B10THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4496840-B1 | SURFACE ACTIVATION OF SILICONE | HASKOLI ISLANDS (IS) | 2026-02-04 | — | — | EP | claimed |
| US-20250215175-A1 | SURFACE ACTIVATION OF SILICONE | HASKOLI ISLANDS (IS) | 2025-07-03 | — | — | US | claimed |
| EP-4496840-A1 | SURFACE ACTIVATION OF SILICONE | Haskoli Islands (IS) | 2025-01-29 | — | — | EP | claimed |
| WO-2023181081-A1 | SURFACE ACTIVATION OF SILICONE | HASKOLI ISLANDS (IS) | 2023-09-28 | — | — | WO | claimed |
| WO-2023144709-A1 | PREPARATION AND APPLICATION OF POLYIMIDE INTERMEDIATES FOR ANTI-CORROSION COATING ON METAL SURFACES | TATA STEEL LIMITED (IN) | 2023-08-03 | — | — | WO | claimed |
| US-20200406347-A1 | COMPOSITIONS COMPRISING EUTECTIC METAL ALLOY NANOPARTICLES | XEROX CORPORATION (US) | 2020-12-31 | — | — | US | claimed |
| US-20200038949-A1 | COMPOSITIONS COMPRISING EUTECTIC METAL ALLOY NANOPARTICLES | XEROX CORPORATION (US) | 2020-02-06 | — | — | US | claimed |
| EP-3507335-A1 | POLYMER COATINGS | Commonwealth Scientific and Industrial Research Organisation (AU) | 2019-07-10 | — | — | EP | claimed |
| WO-2018039721-A1 | POLYMER COATINGS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2018-03-08 | — | — | WO | claimed |
| EP-3288520-A1 | USE OF ACTIVE AGENTS DURING CHEMICAL TREATMENTS | L'OREAL (FR) | 2018-03-07 | — | — | EP | claimed |
| WO-2016179017-A1 | USE OF ACTIVE AGENTS DURING CHEMICAL TREATMENTS | L'OREAL (FR) | 2016-11-10 | — | — | WO | claimed |
| WO-2013020005-A2 | OXAZOLINE POLYMER COMPOSITIONS AND USE THEREOF | ANP TECHNOLOGIES, INC. (US) | 2013-02-07 | — | — | WO | claimed |
| EP-4496840-B1 | SURFACE ACTIVATION OF SILICONE | HASKOLI ISLANDS (IS) | 2026-02-04 | — | — | EP | disclosed |
| US-20250215175-A1 | SURFACE ACTIVATION OF SILICONE | HASKOLI ISLANDS (IS) | 2025-07-03 | — | — | US | disclosed |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | SYMRISE AG (DE) | 2025-05-22 | — | — | US | disclosed |
| EP-3663366-B1 | USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS | SYMRISE AG (DE) | 2025-01-08 | — | — | EP | disclosed |
| WO-1997031899-A1 | SYNTHETIC DERIVATIVES OF RAPAMYCIN AS MULTIMERISING AGENTS FOR CHIMERIC PROTEINS WITH IMMUNOPHILIN DERIVED DOMAINS | ARIAD GENE THERAPEUTICS, INC. (US) | 1997-09-04 | — | — | WO | disclosed |
| EP-0776327-A1 | NEW MULTIMERIZING AGENTS | ARIAD GENE THERAPEUTICS, INC. (US) | 1997-06-04 | — | — | EP | disclosed |
| WO-1996006097-A1 | NEW MULTIMERIZING AGENTS | ARIAD GENE THERAPEUTICS, INC. (US) | 1996-02-29 | — | — | WO | disclosed |
| EP-0269832-A2 | Impact-resistant dimensionnaly stable polyamide moulding compound | BAYER AG (DE) | 1988-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | TTR, TAS2R5, TAS2R50 | ALDH1A1 811/4885TSHR 2090/4885HSD17B10 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.